CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

Total Liabilities Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual total liabilities in 2023 was 1.12 Billion TWD , up 1.94% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 1.06 Billion TWD , down -30.67% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported annual total liabilities of 1.1 Billion TWD in 2022, down -15.16% from previous year.
  • CH Biotech R&D Co., Ltd. reported annual total liabilities of 1.3 Billion TWD in 2021, down -6.71% from previous year.
  • CH Biotech R&D Co., Ltd. reported quarterly total liabilities of 1.06 Billion TWD for 2024 Q2, down -30.67% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported quarterly total liabilities of 1.13 Billion TWD for 2023 Q3, up 3.94% from previous quarter.

Annual Total Liabilities Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual Total Liabilities of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 1.12 Billion TWD 1.94%
2022 1.1 Billion TWD -15.16%
2021 1.3 Billion TWD -6.71%
2020 1.39 Billion TWD 0.0%
2019 - TWD 0.0%

Peer Total Liabilities Comparison of CH Biotech R&D Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Sinon Corporation 6.79 Billion TWD 83.39%
Taiwan Fertilizer Co., Ltd. 26.78 Billion TWD 95.785%
All Cosmos Bio-Tech Holding Corporation 859.54 Million TWD -31.356%